Systematic Portfolios’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-16,647
Closed -$271K – 53
2024
Q2
$271K Buy
+16,647
New +$256K 1.88% 15

Other funds holding TEVA

Systematic Portfolios's TEVA Position: Q3 2024 in Review

Systematic Portfolios sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2024, closing a stake of 16,647 shares — an estimated $271K sold.

Systematic Portfolios first reported a position in TEVA in Q2 2024 and held it in 1 quarter. The position peaked at $271K in Q2 2024. 546 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Systematic Portfolios reported no remaining Teva Pharmaceutical Industries position as of Q3 2024 after selling out during the quarter.
  • Systematic Portfolios sold 16,647 Teva Pharmaceutical Industries shares in Q3 2024, an estimated $271K.
  • Systematic Portfolios first reported a position in Teva Pharmaceutical Industries in Q2 2024 and held it in 1 quarter.
  • Systematic Portfolios's Teva Pharmaceutical Industries position peaked at $271K in Q2 2024.
  • 546 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2024.

Based on Systematic Portfolios's 13F filing for Q3 2024.